Bid mediates anti-apoptotic COX-2 induction through the IKKβ/NFκB pathway due to 5-MCDE exposure

Current Cancer Drug Targets

Volumn 10, Issue 1, 2010, Pages 96-106

  Luo, W ^a,b   Li, J ^a   Zhang, D ^a   Cai, T ^a,b   Song, L ^a   Yin, X M ^c   Desai, D ^d   Amin, S ^d   Chen, J ^a,b   Huang, C ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

5 MCDE; Apoptosis; Bid; COX 2; NF B

Indexed keywords

5 METHYLCHRYSENE 1,2 DIOL 3,4 EPOXIDE; CYCLOOXYGENASE 2; I KAPPA B KINASE BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN BID; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVATION; ENZYME INDUCTION; FIBROBLAST; FUNCTIONAL PROTEOMICS; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; WILD TYPE;

ANIMALS; APOPTOSIS; BH3 INTERACTING DOMAIN DEATH AGONIST PROTEIN; CARCINOGENS; CELLS, CULTURED; CHRYSENES; CYCLOOXYGENASE 2; FIBROBLASTS; I-KAPPA B KINASE; MICE; NF-KAPPA B;

EID: 77950390163     PISSN: 15680096     EISSN: None     Source Type: Journal    
DOI: 10.2174/156800910790980160     Document Type: Article

References (31)

1. Li, J.; Chen, H.; Tang, M. S.; Shi, X.; Amin, S.; Desai, D.; Costa, M.; Huang, C. PI-3K and Akt are mediators of AP-1 induction by 5-MCDE in mouse epidermal Cl41 cells. J. Cell. Biol. 2004, 165, 77-86.
2. Thompson, C. B. Apoptosis in the pathogenesis and treatment of disease. Science 1995, 267, 1456-1462.
3. Green, D. R.; Evan, G. I. A matter of life and death. Cancer Cell. 2002, 1, 19-30.
4. Yin, X. M. Bid, a BH3-only multi-functional molecule, is at the cross road of life and death. Gene. 2006, 369, 7-19.
5. Gross, A. BID as a double agent in cell life and death. Cell. Cycle 2006, 5, 582-584.
6. Ward, M. W.; Rehm, M.; Duessmann, H.; Kacmar, S.; Concannon, C. G.; Prehn, J. H. Real time single cell analysis of Bid cleavage and Bid translocation during caspase-dependent and neuronal caspase-independent apoptosis. J. Biol. Chem. 2006, 281, 5837-5844.
7. Yin, X. M.; Wang, K.; Gross, A.; Zhao, Y.; Zinkel, S.; Klocke, B.; Roth, K. A.; Korsmeyer, S. J. Bid-deficient mice are resistant to Fas-induced hepatocellular apoptosis. Nature 1999, 400, 886-891.
8. Tang, G.; Minemoto, Y.; Dibling, B.; Purcell, N. H.; Li, Z.; Karin, M.; Lin, A. Inhibition of JNK activation through NF-kappaB target genes. Nature 2001, 414, 313-317.
9. Amin, S.; Huie, K.; Melikian, A. A.; Leszczynska, J. M.; Hecht, S. S. Comparative metabolic activation in mouse skin of the weak carcinogen 6-methylchrysene and the strong carcinogen 5-methylchrysene. Cancer Res. 1985, 45, 6406-6442.
10. Song, L.; Li, J.; Zhang, D.; Liu, Z. G.; Ye, J.; Zhan, Q.; Shen, H. M.; Whiteman, M.; Huang, C. IKKbeta programs to turn on the GADD45alpha-MKK4-JNK apoptotic cascade specifically via p50 NF-kappaB in arsenite response. J. Cell. Biol. 2006, 175, 607-617.
11. Ding, J.; Li, J.; Xue, C.; Wu, K.; Ouyang, W.; Zhang, D.; Yan, Y.; Huang, C. Cyclooxygenase-2 induction by arsenite is through a nuclear factor of activated T-cell-dependent pathway and plays an antiapoptotic role in Beas-2B cells. J. Biol. Chem. 2006, 281, 24405-24413.
12. Ding, J.; Zhang, X.; Li, J.; Song, L.; Ouyang, W.; Zhang, D.; Xue, C.; Costa, M.; Huang, C. Nickel compounds render anti-apoptotic effect to human bronchial epithelial Beas-2B cells by induction of COX-2 through IKKbeta /p65-dependent, and IKKalpha - and p50-independent pathway. J. Biol. Chem. 2006, 281, 39022-39032.
13. Luo, X.; Budihardjo, I.; Zou, H.; Slaughter, C.; Wang, X. Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell. 1998, 94, 481-490.
14. Mullen, P. PARP cleavage as a means of assessing apoptosis. Methods Mol. Med. 2004, 88, 171-181.
15. Gu, Q.; Wang, J. D.; Xia, H. H.; Lin, M. C.; He, H.; Zou, B.; Tu, S. P.; Yang, Y.; Liu, X. G.; Lam, S. K.; Wong, W. M.; Chan, A. O.; Yuen, M. F.; Kung, H. F.; Wong, B. C. Activation of the caspase-8/Bid and Bax pathways in aspirin-induced apoptosis in gastric cancer. Carcinogenesis 2005, 26, 541-546.
16. Bae, M. A.; Song, B. J. Critical role of c-Jun N-terminal protein kinase activation in troglitazone-induced apoptosis of human HepG2 hepatoma cells. Mol. Pharmacol. 2003, 63, 401-408.
17. Ghatan, S.; Larner, S.; Kinoshita, Y.; Hetman, M.; Patel, L.; Xia, Z.; Youle, R. J.; Morrison, R. S. p38 MAP kinase mediates bax translocation in nitric oxide-induced apoptosis in neurons. J. Cell. Biol. 2000, 150, 335-347.
18. Korsmeyer, S. J. Bcl-2 initiates a new category of oncogenes: regulators of cell death. Blood 1992, 80, 879-886.
19. Ali-Fehmi, R.; Morris, R. T.; Bandyopadhyay, S.; Che, M.; Schimp, V.; Malone, J. M., Jr.; Munkarah, A. R. Expression of cyclooxygenase-2 in advanced stage ovarian serous carcinoma: correlation with tumor cell proliferation, apoptosis, angiogenesis, and survival. Am. J. Obstet. Gynecol. 2005, 192, 819-825.
20. D'Acquisto, F.; Iuvone, T.; Rombola, L.; Sautebin, L.; Di Rosa, M.; Carnuccio, R. Involvement of NF-kappaB in the regulation of cyclooxygenase-2 protein expression in LPS-stimulated J774 macrophages. FEBS. Lett. 1997, 418, 175-178.
21. Sen, R.; Baltimore, D. Inducibility of kappa immunoglobulin enhancer-binding protein Nf-kappa B by a posttranslational mechanism. Cell. 1986, 47, 921-928.
22. Kerr, J. F.; Winterford, C. M.; Harmon, B. V. Apoptosis. Its significance in cancer and cancer therapy. Cancer 1994, 73, 2013-2026.
23. Hao, X.; Du, M.; Bishop, A. E.; Talbot, I. C. Imbalance between proliferation and apoptosis in the development of colorectal carcinoma. Virchows. Arch. 1998, 433, 523-527.
24. Debatin, K. M.; Krammer, P. H. Death receptors in chemotherapy and cancer. Oncogene 2004, 23, 2950-2966.
25. Okada, H.; Mak, T. W. Pathways of apoptotic and non-apoptotic death in tumour cells. Nat. Rev. Cancer 2004, 4, 592-603.
26. Newmeyer, D. D.; Ferguson-Miller, S. Mitochondria: releasing power for life and unleashing the machineries of death. Cell. 2003, 112, 481-490.
27. Surh, Y. J.; Chun, K. S.; Cha, H. H.; Han, S. S.; Keum, Y. S.; Park, K. K.; Lee, S. S. Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: downregulation of COX-2 and iNOS through suppression of NF-kappa B activation. Mutat. Res. 2001, 480-481, 243-268.
28. Ruefli, A. A.; Ausserlechner, M. J.; Bernhard, D.; Sutton, V. R.; Tainton, K. M.; Kofler, R.; Smyth, M. J.; Johnstone, R. W. The histone deacetylase inhibitor and chemotherapeutic agent suberoylanilide hydroxamic acid (SAHA) induces a cell-death pathway characterized by cleavage of Bid and production of reactive oxygen species. Proc. Nat. Acad. Sci. USA 2001, 98, 10833-10838.
29. Ghosh, S.; Karin, M. Missing pieces in the NF-kappaB puzzle. Cell. 2002, 109, S81-S96.
30. Huang, C.; Ma, W. Y.; Li, J.; Dong, Z. Arsenic induces apoptosis through a c-Jun NH2-terminal kinase-dependent, p53-independent pathway. Cancer Res. 1999, 59, 3053-3058.
31. Yang, T.; Zhang, A.; Honeggar, M.; Kohan, D. E.; Mizel, D.; Sanders, K.; Hoidal, J. R.; Briggs, J. P.; Schnermann, J. B. Hypertonic induction of COX-2 in collecting duct cells by reactive oxygen species of mitochondrial origin. J. Bio. Chem. 2005, 280, 34966-34973.